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ABSTRACT 
Objectives: The normal density of eosinophils in the digestive mucosa of children has 
been rarely addressed despite being important to provide baseline counts for the 
diagnosis of eosinophilic gastrointestinal disorders (EGID). Even though 
histopathological criteria for EGID remains undefined, there has been little consistency 
of results in different populations. We aimed to establish the eosinophil density of the 
normal digestive mucosa in a paediatric population submitted to endoscopic 
procedures that were reported as normal.  
Methods: Biopsies from endoscopies of 33 patients were evaluated. Quantification of 
eosinophils was performed manually. Review of the pathology reports confirmed 
absence of abnormality in the biopsy specimens. Counts were reported as 
mean±standard deviation eosinophils per mm². 
Results: Oesophagus (n=33): eosinophils were uniformly absent in all 
biopsies. Stomach: fundus (n=14; 0.7±0.9), body (n=15; 0.3±0.6) and antrum (n=18; 
0.6±1.5) revealed consistent values in the lamina propria. Small intestine: eosinophil 
counts revealed 17.8±16.6, 14.2±11.8, and 50.4±34.6 in the lamina propria of the bulb 
(n=13), second segment of duodenum (n=13) and ileum (n=16), respectively. Large 
intestine: the highest peak count was observed in the caecum (123; n=16) with a mean 
of 50.8±32.8. The eosinophil counts were lower in the ascending (n=16; 40.2±26.8), 
transverse (n=14; 33.6±21.5), descending (n=15; 39.2±26.1) and sigmoid (n=17; 
25.3±17.4) colon and in the rectum (n=17; 13.6±9.9). Eosinophils were regularly absent 
in the surface epithelium or/and crypt epithelium in these segments.  
Conclusions:  These data provide a baseline count and distribution of eosinophils in 
the gastrointestinal tract of paediatric patients with normal histology, thus expanding 
the scarce published data. 
 
Keywords: eosinophil, gastrointestinal tract, normal, endoscopy, histology. 
Page 9 
 
 
What is known? 
Eosinophils normally reside in the gastrointestinal tract (GI), with different density in 
each segment. There is little information about the normal range of eosinophils in the 
GI tract of children. Different populations may have specific prevalence of eosinophils 
in the GI tract due to allergy or parasitosis therefore comparison and validation of 
normal range is needed.  
 
What is new? 
A detailed analysis of each segment of the GI tract and different layers of the mucosa 
led to calculation of normal density of eosinophils in normal biopsies. This study 
expands the scarce published data and provides contribution to evaluate children with 
suspected eosinophilic gastrointestinal disorders. 
 
 
 
 
 
 
 
 
 
 
 
Page 10 
 
INTRODUCTION 
The importance of eosinophilic gastrointestinal disorders (EGID) has been increasing 
over the past two decades1–3. Collins et al4 defined EGID as diseases that 
characteristically exhibit excessive numbers of eosinophils, in normal and abnormal 
locations, in one or more gastrointestinal (GI) segments. Eosinophils normally reside in 
the GI tract5, so its mere presence does not postulate a diagnosis of EGID. In contrast, 
these cells are normally absent in the oesophagus. The presence of 15 eosinophils per 
high power field (HPF), accepted as the minimum number required for the diagnosis of 
Eosinophilic Oesophagitis (EoE), has being used to define EoE histologically6. Other 
forms of EGID remain with undefined histologic criteria. This illustrates the need to further 
evaluate the normal density of eosinophils in the digestive mucosa. Until now, only a few 
studies7–12 aimed at defining reference values. This is important to provide baseline 
counts as a reference for the diagnosis of EGID. Given the small number of studies, the 
consistency of results in different populations was never fully evaluated. 
We aimed to establish the eosinophil density of the normal digestive mucosa in a 
paediatric population submitted to endoscopic procedures that were reported as normal. 
We evaluated endoscopic biopsies from each segment of the GI tract of paediatric 
patients without organic pathology based on histological and endoscopic reports. These 
data provide a baseline count and distribution of eosinophils in the GI tract of paediatric 
patients with normal histology and provide an additional contribution to evaluate children 
with suspected EGID. 
 
METHODS 
Enrolment: 
The paediatric population included in this study was retrospectively identified and 
randomly selected from the hospital database (SClinico). It consisted of patients that 
underwent endoscopic procedures in the diagnostic process for suspected disease. To 
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be eligible: (1) the final pathology report had to be normal in all evaluated segments and 
(2) the final clinical diagnosis could not involve organic GI disease associated with 
abnormal density of eosinophils (for example: inflammatory bowel disease). Based on 
these criteria, 33 patients were selected for this analysis. Patients diagnosed with 
functional GI disorders (FGID), namely Irritable Bowel Syndrome (IBS), were not 
excluded but analysed separately as defined below. The absence of histological 
abnormality was confirmed by review of the final pathology report and reassessment of 
the slides by a senior pathologist (F.C). Coeliac disease (CD) was excluded by review of 
the pathologic and serologic data recorded at the time of the clinical work-up. Moreover, 
the endoscopy reports were evaluated to verify the absence of mucosal disease at the 
time of the endoscopy. Importantly, all gastric biopsies, from the selected patients, were 
free of Helicobacter pylori organisms and no parasites were detected in all evaluated 
biopsies.  
In the first instance, all biopsies were included to access the mean density of eosinophils 
in each GI segment. Afterwards, we divided the patients in three groups to access 
differences in the mean density of eosinophils between them. The first group included 
patients diagnosed with IBS, the second included patients diagnosed with functional 
dyspepsia (FD) and the third was the control group. The last group included patients with 
GI symptoms who underwent endoscopy but did not have a diagnosis of GI disease after 
the clinical work-up.  
Clinical data such as age, gender, primary reason for endoscopy and the final diagnosis, 
were recorded and are presented in table 1. 
This study was approved by the Ethic Committee for Health (CES) of Centro Hospitalar 
S.João, Porto, Portugal and Medical School of Porto, Portugal. 
Tissue specimens 
Biopsies from endoscopies of 33 patients performed between 2010 and 2017 at Centro 
Hospitalar S.João, Porto, Portugal were included in this study. Selected cases were 
subject to upper gastrointestinal endoscopy (n=15), lower gastrointestinal endoscopy 
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(n=15) or both (n=3). The endoscopic procedures included multiple biopsies of various 
segments of the GI mucosa (table 1). In 18 of the 33 patients, biopsies of the 
oesophagus, stomach and large intestine and in 28, biopsies of the small intestine were 
performed. Evaluated biopsies consisted of 33 specimens of oesophagus (proximal, mid 
and distal segment); 47 of stomach (fundus, body and antrum); 42 of small intestine 
(bulb, second segment of duodenum [SSD] and ileum); and 95 of large intestine 
(caecum, ascending, transverse, descending and sigmoid colon and rectum).  
Selection of areas and counting 
After selection of the patients to be included in this study, we retrieved the haematoxylin 
and eosin histology slides of each patient to count the eosinophils. These slides were 
reviewed together with another pathologist (P.C) to select the areas of interest for this 
study. 
In each area, four images were taken at 400x magnification with each image having an 
equivalent representation of surface epithelium and lamina propria of the mucosa. 
Oesophagus specimens did not include lamina propria and were composed only of 
stratified squamous epithelium.  Each image represented a HPF (400x) which included 
an area of 0.245 mm². Images were taken with the Olympus BX 43 microscope (camera 
Olympus DP73) to obtain high quality digital colour images of the areas to be counted. 
This assured consistency between pathologist’s counting’s. 
Each image was used to count eosinophils; the entire image including the edges was 
used for counting. Counting was conducted manually with ImageJ software (National 
Institutes of Health) that counts the clicks on each eosinophil (Cell Counter plugin). 
Eosinophils were counted in two distinct locations: in the surface epithelium and in the 
lamina propria. Eosinophils were counted if there was an identifiable portion of the 
nucleus present along with associated granules. Eosinophils located in the basement 
membrane of the surface epithelium were considered as intraepithelial eosinophils. 
Eosinophils that were present within the epithelial layer of the crypt or within the crypt 
lumen were considered to be within the crypts. Eosinophils present in the mucosa that 
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were neither in the surface epithelium nor the crypts were considered within the lamina 
propria. Inflammatory cells within blood vessels, in Peyer’s Patch or other large lymphoid 
aggregates were not quantified in this analysis. ImageJ was used by two pathologists, in 
a double-blind setting. Subsequently data were compared and reviewed by a senior 
pathologist (F.C). Representative histologic features of tissue specimens from each 
segment of the GI tract are shown in figure 1. 
After manual counting with ImageJ software, the number of eosinophils in each image 
was entered into an Excel spreadsheet. Density of eosinophils was reported as 
mean±standard deviation eosinophils per mm².  
Statistical methods 
The Excel file was converted into a statistical data analysis (SPSS) database. Mean, 
standard deviation, median, minimum and maximum counts were calculated for all 
evaluated segments using SPSS software (IBM® SPSS® Statistics, version 25). The 
results in each region are summarized in table 2. The peak count represents the highest 
density of eosinophils observed in each GI segment. Because all data were 
nonparametric, the Mann-Whitney test was conducted for comparisons between the 
three groups. A P value < 0.05 was considered to be statistically significant.  
 
RESULTS 
Patient characteristics: 
A total of 33 paediatric patients (21 females and 12 males) were included in our study. 
The mean age was 14.6±3.4 years. The most common reason for endoscopy was 
dyspepsia (n=11). Some of the symptoms were observed together (diarrhoea and 
abdominal pain were both present in 3 patients). The most common final diagnosis was 
FD (n=10). In 12 clinical cases the final diagnosis report recorded in the database only 
excluded GI pathology as cause for the symptoms. 
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Oesophagus 
Eosinophils were uniformly absent in the epithelium. Given the consistency of 
eosinophil counting’s between the three segments evaluated, the results in 
oesophagus were considered as a single segment (n=33). 
Stomach 
Biopsies from the fundus (n=14) demonstrated a mean value of 0.7±0.9/mm² in the 
lamina propria. Only in half of the evaluated areas (n=7) eosinophils were observed. 
Eosinophilic density in the body (n=15) was 0.3±0.6/mm² in the lamina propria. 
Eosinophils were only present in 3 of the evaluated areas. The peak count was 3 and 2 
eosinophils/mm², in the fundus and body, respectively. In the antrum (n=18) were 
0.6±1.5/mm² in the lamina propria. The peak count was 6 eosinophils/mm² and 
eosinophils were not observed in 14 of the analysed areas. All the evaluated segments 
revealed consistent eosinophil counting. Additionally, eosinophils were uniformly 
absent in the surface epithelium of the three evaluated segments.  
Small Intestine 
Biopsies from the bulb (n=13) revealed 17.8±16.6/mm² in the lamina propria and a 
peak count of 49 eosinophils/mm². The number of eosinophils/mm² present in the 
surface epithelium was 0.9±1.9, with a peak count of 7. Eosinophilic density in the 
lamina propria of the SSD (n=13) was 14.2±11.8/mm², with 1.4±2.1/mm² in the surface 
epithelium. The peak count observed in this segment was 41/mm² in the lamina propria 
and 7/mm² in the surface epithelium. Evaluation of biopsies from the ileum (n=16) 
revealed 50.4±34.6/mm² with a peak count of 109/mm². Distribution of eosinophils in 
the ileum was noted to be patchy, with a range of 3 to 109/mm². Eosinophils in the 
surface epithelium ranged from 0 to 9/mm² with a mean value of 3.3±2.8/mm². 
Large Intestine 
The mean number and the peak count of eosinophils in the lamina propria of the 
caecum (n=16) were the highest amongst evaluated segments (50.8±32.8 and 
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123/mm², respectively). The eosinophil counts were uniformly lower in the lamina 
propria of the other evaluated segments of the colon.  
In the ascending colon (n=16) we observed a mean value of 40.1±26.8/mm² with a 
peak count of 86/mm².  In the transverse colon (n=14) the eosinophil counting revealed 
33.6±21.5/mm² with a peak count of 68/mm². In the descending colon (n=15), 
39.2±26.1/mm² and a peak count of 90/mm². In the sigmoid colon (n=17), 
25.3±17.4/mm² with a peak count of 55/mm². Finally, evaluated biopsies from the 
rectum (n=17) revealed 13.6±9.9/mm² and a peak count of 43/mm². Distribution of 
eosinophils in the large intestine was noted to be patchy as observed in the ileum. In 
the caecum, eosinophil counting ranged from 2 to 123/mm². In the other GI segments, 
we observed a similar amplitude of the eosinophil counting, with a lower peak count.  
Eosinophils, as observed in the upper GI tract, were regularly absent in the surface and 
crypt epithelium in these segments. Caecum was the segment with the highest 
eosinophilic density in the surface and crypt epithelium (4.1±3.7/mm²) and a peak 
count of 13/mm². Eosinophil numbers in the surface epithelium and crypt epithelium in 
the colon were: 2.9±3.0/mm² in the ascending; 2.9±3.0/mm² in the transverse; 
2.9±2.6/mm² in the descending; 2.3±2.3/mm² in the sigmoid; and 1.8±2.3/mm² in the 
rectum. 
Effect of IBS and FD in the number of eosinophils  
FGID was the final diagnosis in 21 of the selected patients for this study. IBS was the 
final diagnosis in 6 patients. The symptoms of the 15 remaining patients were attributed 
to other FGID, namely FD (n=10), functional constipation (n=3), functional abdominal 
pain (n=1) and functional dysphagia (n=1). In order to compare the number of eosinophils 
between patients with FGID and no GI disease, we divided our population in 3 groups. 
We compared the mean density between the IBS and the control patients and between 
the FD and control patients, using the Mann Whitney test. In the IBS group we only had 
one biopsy specimen of stomach and small intestine (except ileum) so we were not able 
to make comparisons with the control group in these segments. The same occurred with 
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the ileum and large intestine segments in the FD group. Patients with other FGID were 
not included in this analysis. As eosinophils were uniformly absent in the oesophagus, 
this segment was not included in the comparison analysis. The number of eosinophils in 
the lamina propria was the only area compared between the groups. Table 3 shows the 
mean number of eosinophils in each group and P values of the comparisons made 
between the groups. The paired data did not reveal significant differences in the 
evaluated segments of the GI tract among the three groups. Notably, the patchiness in 
the distribution of eosinophils previously observed was maintained in all groups (figure 
2).  
 
DISCUSSION  
EGID are a global growing concern which still faces limitations regarding its proper 
diagnosis. In most segments of the GI tract there is no consensus on specific limits for 
normality regarding the number of eosinophils. The scattered published data 
addressing the normal content of eosinophils includes three reports in children and four 
in adults.  
As such, our goal was to determine the eosinophil content of the normal digestive 
mucosa in a paediatric population and to expand the scarce data available for each GI 
segment. 
In the oesophagus we measured the content of eosinophils in the surface epithelium of 
the proximal, mid and distal segments. We did not differentiate each segment of the 
oesophagus as result of the absence of eosinophils in this particular area. These 
findings were consistent with other reports8,11. 
We also measured the mean and maximum number of eosinophils/HPF with Olympus 
BX43 to allow comparisons with publications reported in eosinophils/HPF. Although 
most of them had published their results in eosinophils/HPF8,9, the most recent 
indications recommend that authors use eosinophils/mm². The mean and maximum 
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number/HPF were, respectively, 0.2 and 3 (fundus), 0.1 and 1 (body), 0.2 and 2 
(antrum), 4.4 and 17 (bulb), 3.6 and 16 (SSD), 12.6 and 31 (ileum), 12.7 and 36 
(caecum), 10.0 and 23 (ascending colon), 8.4 and 22 (transverse colon), 9.9 and 32 
(descending colon), 6.3 and 18 (sigmoid colon) and 3.3 and 17 (rectum). 
Contrary to published data8,10,11, eosinophils were barely present in the segments of the 
stomach. In fact, most of the gastric biopsies were devoid of eosinophils. The highest 
peak count was reported in the fundus (3 eosinophils/HPF) whereas Debrosse et al8 
observed a peak count of 9 eosinophils/HPF in the same segment. 
Our results indicate that every other GI segment has significant and variable number of 
eosinophils in the lamina propria. The range of eosinophil counting observed in our 
study group was consistent with most of the previous published data8,9,11,12. Generally, 
the number of eosinophils significantly increased from the oesophagus to the caecum 
and gradually decreased in the large intestine. However, in our report the eosinophilic 
density in the bulb was higher than in the SSD. To the best of our knowledge this is the 
first report evaluating biopsies from the bulb and SSD separately. Moreover, we 
observed a slight increase of the eosinophilic density and peak count in the descending 
colon. This pattern of distribution was different from previous studies. Other reports 
have differentiated segments in the large intestine, but not as many as this study. Until 
now, the majority of studies has shown a progressive gradient in the eosinophilic 
density from the oesophagus to the caecum and a gradual decrease along the large 
intestine8,11. In the report of Saad9 there was another peak in the rectosigmoid 
segment. Both our study and the latest published results8,9,11,12 showed consistently 
that a one-fits-all number may not be the best option for defining the limits of normality 
in the colon. The same may be applied to the small intestine where the normal content 
of eosinophils in the ileum is clearly superior to the segments of the duodenum. 
We also evaluated the presence of eosinophils in the surface and crypt epithelium. Our 
results showed that eosinophils are primarily present in the lamina propria and not in 
the surface epithelium. These findings were consistent with previous published data8. 
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We selected a paediatric population previously submitted to endoscopy that was 
reported as normal. It is important to note that endoscopic procedures, especially in 
paediatrics, have very strict criteria and indications. Therefore, our patients had GI 
symptoms and needed endoscopy to confirm or exclude GI pathology. In some of them 
the cause of the symptoms was not due to GI disease but remained undefined. We 
believe that exclusion of GI disease and normal associated histology of the mucosa 
were sufficient criteria to include these patients in our analysis. 
Nowadays, in the presence of normal villous architecture and GI symptoms in children 
it is recommended to evaluate the number of duodenal intraepithelial lymphocytes as 
those may be increased in some diseases like CD13,14. Although we did not address the 
number of intraepithelial lymphocytes, the counts were normal at the time of clinical 
work-up. 
It is increasingly apparent that eosinophils may play a pathogenic role in FGID15,16. 
Duodenal eosinophilia has been reported in FD17. IBS has also been linked to 
increased mast cells and other allergic-immune cells in the GI tract.18 Regardless, we 
included patients with confirmed FGID. We evaluated the number of eosinophils 
separately in the IBS, FD and control patients. Despite small number of the cases, our 
results indicate that the number of eosinophils of FD and IBS patients was not 
statistically different than the number of eosinophils recorded in control patients. 
Moreover, the highest mean in the duodenum recorded in the FD group was 17.6±15.9 
eosinophils/mm²  whereas Wauters et al17 reported a median of 151 eosinophils/mm².  
Patients diagnosed with other FGID were not compared because the role of 
eosinophils in those disorders is less studied. Because we evaluated more segments 
separately, our sample size in each segment was slightly inferior compared to other 
similar studies. However, our report revealed a consistent result that is comparable to 
previously published series.  
We did not consider the seasonal variation in the number of eosinophils in our study, 
as reported by Polydorides et al19. Their data described an increase in the number of 
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eosinophils in colonic samples obtained between April and May. However, the 
relationship between allergen exposure and colonic eosinophilia was not significant. 
Another study concluded for no seasonal effect in the number of eosinophils10. 
We also dismissed the geographic variation even though it has been reported 
previously in Pascal et al20. Geographic variations in the number of eosinophils can be 
expected because allergy or parasitosis21, recognizable causes of tissue eosinophilia, 
might differ between countries. Several studies were conducted in various regions of 
Portugal to access the prevalence of GI parasitosis between 1970 and 199022,23. These 
studies showed a significant decrease in the prevalence of all GI parasites, due to the 
improvement in health care and generalized chemoprophylaxis of GI parasitosis. More 
recent studies reported comparable results24,25. We can assume that, currently, 
parasitosis in Portugal is not a significant cause of GI eosinophilia which could bias our 
results.  Also, the low prevalence recorded in the various regions may allow 
generalization of our results.  
In summary, these data provide a baseline count and distribution of eosinophils in the 
GI tract of paediatric patients with normal histology. Our analysis included patients with 
FGID who showed comparable results with the other patients. We believe that 
normal variations in the normal density of mucosal eosinophils should be first evaluated 
within a specific region. This is the first report addressing the normal distribution of 
eosinophils in an European population. Furthermore, we provide baseline values for GI 
segments which were not evaluated separately before, providing an additional 
contribution to evaluate children with suspected EGID. 
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ANEXOS 
Figure 1 legend:  
Photographies of histologic samples (haematoxylin and eosin) from biopsies of the 
gastrointestinal tract. A, Oesophageal epithelium. B, Gastric mucosa (Fundus). C, 
Duodenal mucosa (Bulb). D, Ileal mucosa. E, Descending colon mucosa. F, Rectal 
mucosa. The arrows indicate some of the eosinophils present in the lamina propria. 
Insets of B through F are high-power images clearly illustrating eosinophils. 
 
Figure 2 legend: 
Eosinophil levels in gastrointestinal segments of the various groups. A shows the 
differences in the distribution of eosinophils between the patients with functional 
dyspepsia and controls. B shows the differences in the distribution of eosinophils 
between the patients with Irritative Bowel Syndrome and controls. The solid black line 
represents the mean eosinophil level in the lamina propria of the respective segment. 
Abbreviations: FD, Functional Dyspepsia; IBS, Irritative Bowel Syndrome; SSD, second 
segment of duodenum; AC, ascending colon; TC, transverse colon; DC, descending 
colon; SC, sigmoid colon 
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TABLE 1:  
Title: Clinical data of enrolled patients 
 
Legend: Patients characteristics are described, including age, gender (F: female; M: 
male), reason for endoscopy and the final diagnosis. Abbreviations: AP, abdominal 
pain; EGIP, exclusion of gastrointestinal pathology; IBS, Irritable Bowel Syndrome; 
IDA, iron deficiency anaemia; PE, proximal oesophagus; ME, medium oesophagus; 
DE: distal oesophagus; F, fundus; BS, body of stomach; A, antrum; B, bulb; SSD, 
second segment of duodenum; I, ileum; C, caecum; AC, ascending colon; TC, 
transverse colon; DC, descending colon; SC, sigmoid colon; R, rectum. 
 
 
 
 
 
 
 
 
 
 
 
 
Patient 
number 
Age Gender Reason for UGE/LGE Final diagnosis Biopsy  
1 18  F Dyspepsia Functional Dyspepsia PE, ME, DE, F, BS, A, B 
2 9 F Recurrent emesis/Dyspepsia Functional Dyspepsia DE, A, BS, SSD 
3 10  M Dyspepsia Functional Dyspepsia DE, A 
4 17 M Dyspepsia EGIP PE, ME, DE, F, BS, A, B, SSD 
5 16 M Dyspepsia Functional Dyspepsia DE, F, BS, A 
6 15 F Enteropathy not confirmed EGIP PE, DE, F, BS, A, B, SSD 
7 17 F Recurrent emesis /Dyspepsia Functional Dyspepsia DE, F, BS, A, B, SSD 
8 14 F Dyspepsia Functional Dyspepsia DE, F, BS, A 
9 12 F Dyspepsia Functional Dyspepsia PE, ME, DE, F, BS, A, B, SSD 
10 17 F Recurrent emesis /Dyspepsia EGIP DE, F, BS, A, B, SSD 
11 17 F Dyspepsia EGIP PE, ME, DE, A, SSD 
12 8 M Dysphagia Functional Dyspepsia PE, ME, DE, F, BS, A, B, SSD 
13 14 M Dyspepsia Functional Dyspepsia ME, F, BS, A, B, SSD 
14 8 M Dysphagia Functional Dysphagia PE, ME, DE, F, BS, A, B, SSD 
15 15 M Dysphagia/AP  IBS DE, F, BS, A, B, SSD, I, C, AC, TC, DC, SC, R 
16 16 M IDA EGIP I, C, AC, SC 
17 17 F Rectal bleeding/Diarrhoea IBS I, C, AC, TC, DC, SC, R 
18 14 F Diarrhoea/AP EGIP PE, DE, F, BS, A, B, SSD 
19 14 F Diarrhoea IBS SC, R 
20 18 F Recurrent emesis /AP EGIP I, C, AC, TC, DC, SC, R 
21 16 F Rectal bleeding/AP IBS I, C, AC, TC, DC, SC, R 
22 17 M Diarrhoea IBS DE, BS, A, B, I, C, AC, TC, DC, SC, R 
23 18 F AP Functional Dyspepsia I, AC, TC, DC, SC, R 
24 18 F Diarrhoea/AP Functional AP I, C, AC, TC, DC, SC, R 
25 11 F Diarrhoea/AP EGIP I, C, AC, TC, DC, SC, R 
26 8 M Rectal bleeding/Constipation  Functional Constipation I, C, AC, TC, DC, SC, R 
27 18 F Diarrhoea IBS I, C, AC, TC, DC, SC, R 
28 18 F IDA/AP EGIP PE, DE, F, A, B, SSD, I, C, AC, S, R 
29 14 F IDA EGIP I, C, AC, TC, DC, SC, R 
30 12 M Rectal bleeding EGIP I, C, AC, DC, SC, R 
31 11 M Rectal bleeding EGIP I, C, AC, TC, DC, SC, R 
32 18 F Rectal bleeding/Constipation  Functional Constipation  I, C, TC, DC, SC, R 
33 16 F Constipation/AP Functional Constipation  C, AC, TC, DC, SC, R 
Page 27 
 
TABLE 2  
Title: Eosinophilic density in the gastrointestinal tract 
 
Legend: The mean number (±standard deviation), median and maximum number of 
eosinophils per mm² for each anatomical region of the gastrointestinal tract and each 
region of the mucosa is shown. Abbreviations: N/A, not applicable. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gastrointestinal 
segment 
Lamina propria Surface or crypt epithelium 
Mean Median Max Mean Median Max 
Oesophagus N/A N/A N/A 0±0 0 0 
Fundus 0.7±0.9 0.5 3 0±0 0 0 
Body of stomach 0.3±0.6 0 2 0±0 0 0 
Antrum 0.6±1.5 0 6 0±0 0 0 
 Bulb 17.8±16.6 14.0 49 0.9±1.9 0 7 
Second segment of duodenum 14.2±11.8 11.0 41 1.4±2.1 1.0 7 
Ileum 50.4±34.6 45.5 109 3.3±2.8 4.0 9 
Caecum 50.8±32.8 49.0 123 4.1±3.7 3.0 13 
Ascending colon 40.2±26.8 34.5 86 2.9±3.0 2.0 9 
Transverse colon 33.6±21.5 36.5 68 2.9±3.0 2.0 11 
Descending colon 39.2±26.1 43.0 90 2.9±2.6 2.0 10 
Sigmoid colon 25.3±17.4 23.0 55 2.3±2.3 2.0 8 
Rectum 13.6±9.9 15.0 43 1.8±2.3 1.0 9 
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TABLE 3 
Title: Effect of functional gastrointestinal disorders on eosinophil number in the 
gastrointestinal tract (number/mm²) 
 
 
Legend: The mean (±standard deviation) and maximum number of eosinophils 
calculated for each segment in the 3 groups is shown. No statistical differences were 
noted between the groups. Abbreviations: FD, functional dyspepsia; IBS, Irritable 
Bowel Syndrome; N/A, not applicable. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gastrointestinal 
segment 
Mean ± standard deviation (maximum) P Value 
IBS FD Controls IBS vs Controls FD vs Controls 
Fundus N/A 0.6±1.1 (3) 0.6±0.5 (1) N/A 0.459 
Body of stomach N/A 0±0 (0) 0.4±0.5 (1) N/A 0.062 
Antrum N/A 0.3±0.9 (3) 0.3±0.5 (1) N/A 0.339 
Bulb N/A 17.6±15.9 (49) 10.8±14.4 (32) N/A 0.450 
Second segment of duodenum N/A 16.0±12.6 (35) 9.8±4.1 (15) N/A 0.3602 
Ileum 31.8±29.2 (76) N/A 67.0±41.1 (109) 0.078 N/A 
Caecum 37.6±36.9 (96) N/A 54.7±39.2 (123) 0.522 N/A 
Ascending colon 28.7±22.4 (67) N/A 49.7±32.9 (86) 0.200 N/A 
Transverse colon 31.4±29.0 (68) N/A 23.0±15.9 (38) 0.712 N/A 
Descending colon 40.6±25.4 (65) N/A 35.4±36.7 (90) 0.602 N/A 
Sigmoid colon 30.2±21.2 (55) N/A 16.4±12.8 (36) 0.255 N/A 
Rectum 13.2±7.9 (21) N/A 9.4±7.5 (18) 0.624 N/A 
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